Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-18 · accession 0001562180-21-007180 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-19 | 2021-11-18 | SNDX | Egros Fabrice | Dir | S - Sale+OE | $18.03 | -14.0K | 16.0K | -47% | -$253.0K |
| DM | 2021-11-19 | 2021-11-18 | SNDX | Egros Fabrice | Dir | M - OptEx | $8.93 | +14.0K | 30.0K | +88% | +$125.3K |
| DM | 2021-11-19 | 2021-11-18 | SNDX | Egros Fabrice | Dir | M - OptEx | $0.00 | -14.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-18 | S | D | 14,000 | $18.03 | 16,000 | D | — | — | (F2) The sale prices ranged from $18.03 to $19.03. |
| 2 | Common | Common Stock | 2021-11-18 | S | D | 30 | $18.03 | 16,000 | D | — | — | (F2) The sale prices ranged from $18.03 to $19.03. |
| 3 | Common | Common Stock | 2021-11-18 | M | A | 30 | $7.88 | 16,030 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-18 | M | A | 14,000 | $8.93 | 30,000 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2021-11-18 | M | D | 30 | $0.00 | 0 | D | $7.88 · — to 2029-06-10 | 0 Common Stock | (F3) This option is fully vested. |
| 6 | Derivative | Stock Options (Right to buy) | 2021-11-18 | M | D | 14,000 | $0.00 | 0 | D | $8.93 · — to 2028-05-23 | 0 Common Stock | (F3) This option is fully vested. |